$OBLN ReShape Lifesciences Inc. Insider Trading Week 41/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ReShape Lifesciences Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ReShape Lifesciences Inc. in week 41/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 14,271 | 0 | 0 | |
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 20,583 | 0 | 0 | |
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DP VII ASSOCIATES LP | 10% Owner | Option Exercise | C | 0.00 | 11,083 | 0 | 0 | |
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DP VII ASSOCIATES LP | 10% Owner | Buy | C | 0.00 | 49,570 | 0 | 49,570 | 0 to 49.6 K |
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 482,326 | 0 | 0 | |
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 597,207 | 0 | 0 | |
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 836,722 | 0 | 0 | |
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 1,206,836 | 0 | 0 | |
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Option Exercise | C | 0.00 | 649,835 | 0 | 0 | |
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | C | 0.00 | 3,985,970 | 0 | 3,985,970 | 0 to 4 M |
| Oct 14 2016 | OBLN | OBALON THERAPEUTIC ... | Kamdar Kim P. | Director | Buy | P | 15.00 | 13,400 | 201,000 | 13,400 | 0 to 13.4 K |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Option Exercise | C | 6.19 | 4,037 | 24,996 | 4,037 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Option Exercise | C | 6.19 | 4,037 | 24,996 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Option Exercise | C | 0.00 | 60,290 | 0 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Option Exercise | C | 0.00 | 47,629 | 0 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Option Exercise | C | 0.00 | 119,441 | 0 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Option Exercise | C | 0.00 | 161,504 | 0 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Option Exercise | C | 0.00 | 40,995 | 0 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Option Exercise | C | 0.00 | 266,829 | 0 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Option Exercise | C | 0.00 | 143,677 | 0 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Buy | C | 0.00 | 60,290 | 0 | 341,235 | 280.9 K to 341.2 K (+21.46 %) |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Buy | C | 0.00 | 47,629 | 0 | 546,233 | 498.6 K to 546.2 K (+9.55 %) |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Buy | C | 0.00 | 119,441 | 0 | 280,945 | 161.5 K to 280.9 K (+73.96 %) |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Buy | C | 0.00 | 161,504 | 0 | 161,504 | 0 to 161.5 K |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Buy | C | 0.00 | 40,995 | 0 | 498,604 | 457.6 K to 498.6 K (+8.96 %) |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Buy | C | 0.00 | 266,829 | 0 | 457,609 | 190.8 K to 457.6 K (+139.86 %) |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Director | Buy | C | 0.00 | 190,780 | 0 | 190,780 | 0 to 190.8 K |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | Norwood Matthew | VP of Sales | Buy | P | 15.00 | 1,000 | 15,000 | 1,000 | 0 to 1,000 |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | INTERWEST PARTNERS X LP | 10% Owner | Option Exercise | C | 0.00 | 373,803 | 0 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | INTERWEST PARTNERS X LP | 10% Owner | Option Exercise | C | 0.00 | 464,494 | 0 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | INTERWEST PARTNERS X LP | 10% Owner | Option Exercise | C | 0.00 | 1,615,041 | 0 | 0 | |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | C | 0.00 | 373,803 | 0 | 2,453,338 | 2.1 M to 2.5 M (+17.98 %) |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | C | 0.00 | 464,494 | 0 | 2,079,535 | 1.6 M to 2.1 M (+28.76 %) |
| Oct 12 2016 | OBLN | OBALON THERAPEUTIC ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | C | 0.00 | 1,615,041 | 0 | 1,615,041 | 0 to 1.6 M |